View Older Stories View More Recent Stories
-
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
-
US jobless claims edge up, but 'no-hire, no-fire' trend remains intact
-
Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
-
Brazil's fish industry, hit with a 50% US tariff, seeks a lifeline
-
Bank of England cuts rates to 4% after narrow 5-4 vote
-
Kaltura Announces Financial Results for Second Quarter 2025
-
Altice USA Reports Second Quarter 2025 Results
-
NeueHealth Reports Second Quarter 2025 Results
-
Siemens meets quarterly profit forecast, but weaker dollar drags overall results
-
Vasta Announces Second Quarter 2025 Results
-
EnerSys Reports First Quarter Fiscal 2026 Results
-
ALAMO GROUP ANNOUNCES STRONG OPERATING RESULTS FOR THE SECOND QUARTER 2025
-
Biote Reports Second Quarter 2025 Financial Results
-
Airgain® Reports Second Quarter 2025 Financial Results
-
TKO Reports Second Quarter 2025 Results
-
Bumble Inc. Announces Second Quarter 2025 Results
-
Why Trump is Obsessed with Tariffs on Aluminum, Steel and Copper
-
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
MasterBrand to acquire American Woodmark in $2.4 billion all-stock deal
-
MasterBrand and American Woodmark to Combine in an All-Stock Transaction to Accelerate Value Delivery Through:
-
MasterBrand Reports Second Quarter 2025 Financial Results
-
Bayer investors concerned soccer transfers inflated earnings, shares drop
-
Novo Nordisk's weight loss challenge in five charts
-
New Zealand labour market remains soft, adds to rate-cut expectation
-
Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending - Hagens Berman
-
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
-
Hinge Health Reports Second Quarter 2025 Financial Results
-
OraSure Announces Second Quarter 2025 Financial Results
-
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results
-
Raymond James Reiterates Market Perform Rating on Palantir Technologies Inc. (PLTR), 'Impeccable Results yet the Best Is yet to Come – Raising Street High Estimates Again'
-
Cushman & Wakefield Reports Financial Results for the Second Quarter 2025
-
Broadridge Reports Fourth Quarter and Fiscal 2025 Results
-
Nomad Internet Launches “NomadCares” $75 Redemption Program
-
Nissan begins talks with union to cut jobs at European regional office
-
58% of Americans say their finances are in crisis, Achieve survey finds
-
TrueBlue Reports Second Quarter 2025 Results
-
BayFirst discontinues SBA loan program, cuts 51 jobs
-
Dorman Products, Inc. Reports Second Quarter 2025 Results and Raises Full Year 2025 Guidance
-
Wayfair Announces Second Quarter 2025 Results, Reports Highest Revenue Growth and Profitability Since 2021
-
Berkshire takes $3.8 billion Kraft Heinz write-down, operating profit falls
-
Trump administration blocks funding for CDC health programs, WSJ reports
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
Republican US Representative Brian Steil booed over Trump tariffs
-
Data credibility fears fueled after Trump orders firing of labor official
-
South Africa's finance minister and central bank governor at odds over inflation target
-
Daimler Truck warns of tougher H2 after outlook cut, shares lower
-
China's solar giants quietly shed a third of their workforces last year
